HomeInsightsStock Comparison

Novartis India Ltd vs Rpg Life Sciences Ltd Stock Comparison

Novartis India Ltd vs Rpg Life Sciences Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Novartis India Ltd is ₹ 1051 as of 16 Jul 12:04.
  • The P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 19.2 on March 2025 . This represents a CAGR of -26.63% over 6 yearsThe P/E Ratio of RPG Life Sciences Ltd changed from 9.7 on March 2020 to 20.6 on March 2025 . This represents a CAGR of 13.37% over 6 years.
  • The Market Cap of Novartis India Ltd changed from ₹ 1240 crore on March 2020 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.73% over 6 yearsThe Market Cap of RPG Life Sciences Ltd changed from ₹ 281.91 crore on March 2020 to ₹ 3766 crore on March 2025 . This represents a CAGR of 54.04% over 6 years.
  • The revenue of Novartis India Ltd for the Mar '25 is ₹ 94.51 crore as compare to the Dec '24 revenue of ₹ 103.6 crore. This represent the decline of -8.77% The revenue of RPG Life Sciences Ltd for the Mar '25 is ₹ 258.05 crore as compare to the Dec '24 revenue of ₹ 176.02 crore. This represent the growth of 46.6%.
  • The ebitda of Novartis India Ltd for the Mar '25 is ₹ 34.54 crore as compare to the Dec '24 ebitda of ₹ 36.18 crore. This represent the decline of -4.53% The ebitda of RPG Life Sciences Ltd for the Mar '25 is ₹ 140.45 crore as compare to the Dec '24 ebitda of ₹ 52.47 crore. This represent the growth of 167.68%.
  • The net profit of Novartis India Ltd changed from ₹ 20.26 crore to ₹ 29.3 crore over 8 quarters. This represents a CAGR of 20.26% The net profit of RPG Life Sciences Ltd changed from ₹ 22.1 crore to ₹ 117.35 crore over 8 quarters. This represents a CAGR of 130.43% .
  • The Dividend Payout of Novartis India Ltd changed from 244.84 % on March 2020 to 61.15 % on March 2025 . This represents a CAGR of -20.64% over 6 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 24.66 % on March 2020 to 18.05 % on March 2025 . This represents a CAGR of -5.07% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About RPG Life Sciences Ltd

  • RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
  • The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
  • During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
  • On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

Novartis India Ltd News Hub

News

Novartis India to discuss results

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

01 Jul 2025 10:25

News

Novartis India schedules AGM

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be ...

Read more

10 May 2025 09:38

News

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 2025 09:38

News

Novartis India to announce Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025....

Read more

28 Mar 2025 09:32

News

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

28 Dec 2024 09:37

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 2024 10:07

RPG Life Sciences Ltd News Hub

News

RPG Life Sciences schedules AGM

RPG Life Sciences announced that the 18th Annual General Meeting(AGM) of the company will ...

Read more

16 Jun 2025 15:14

News

Board of RPG Life Sciences recommends special dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

Board of RPG Life Sciences recommends final dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

RPG Life edges higher after Q4 PAT rises 64% YoY to nearly Rs 22 crore

Net sales rose by 12.7% year-over-year (YoY) to Rs 143.09 crore during the period under re...

Read more

29 Apr 2025 11:35

News

RPG Life Sciences to hold board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 28 April...

Read more

22 Apr 2025 09:39

News

RPG Life Sciences soars as PAT jump 32% YoY to Rs 35 crore in Q3 FY25

Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in ...

Read more

27 Jan 2025 11:51

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of RPG Life Sciences Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for RPG Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Novartis India Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Novartis India Ltd or RPG Life Sciences Ltd?

Market cap of Novartis India Ltd is 2,607 Cr while Market cap of RPG Life Sciences Ltd is 4,228 Cr

What are the key factors driving the stock performance of Novartis India Ltd and RPG Life Sciences Ltd?

The stock performance of Novartis India Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and RPG Life Sciences Ltd?

As of July 16, 2025, the Novartis India Ltd stock price is INR ₹1056.15. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2556.95.

How do dividend payouts of Novartis India Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Novartis India Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions